Armistice Capital Master Fund Ltd. insider trades
Armistice Capital Master Fund Ltd. has filed 4 Form 4s with the SEC that we hold, for Avalo Therapeutics, Inc. (AVTX) (10% owner) and Tenax Therapeutics, INC. (TENX) (Director, 10% owner). Across all of them we count 5 purchases worth $756.6K and 2 sales worth $2.2M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 2,746,138 shares of Avalo Therapeutics, Inc. worth $1.7M, dated 2023-06-26. The first filing on our record is dated 2022-01-11 and the latest 2023-06-28.
Avalo Therapeutics, Inc. (AVTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-01-07 | P, purchase reported on Form 4 | 137,900 | $143.4K | 2022-01-11 |
| 2022-01-10 | P, purchase reported on Form 4 | 491,097 | $486.2K | 2022-01-11 |
| 2022-01-11 | P, purchase reported on Form 4 | 16,003 | $15.4K | 2022-01-11 |
| 2022-02-24 | P, purchase reported on Form 4 | 100,000 | $80.0K | 2022-02-28 |
| 2022-02-25 | P, purchase reported on Form 4 | 40,000 | $31.6K | 2022-02-28 |
| 2023-06-26 | S, sale reported on Form 4 | 2,746,138 | $1.7M | 2023-06-28 |
| 2023-06-27 | S, sale reported on Form 4 | 937,404 | $487.5K | 2023-06-28 |
Tenax Therapeutics, INC. (TENX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1633584) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms